Clinical supply optimization – clarifying the relative risk of change

Clinical supply optimization – clarifying the relative risk of change

The clinical team at this top ten pharmaceutical company struggled with the delicate balancing act between controlling the costs of a major oncology trial and making strategic investments that would pay off in the long term. Read this case study to learn how Thermo Fisher Scientific was able to provide a 25% reduction in shipment volumes over a three month monitored period with no increase in stock outs at the site or depot level saving the sponsor several million dollars in clinical trial supply costs.

Resource Library

Additional Resources